Balloon in the womb: new device aims to save babies with underdeveloped lungs
NCT ID NCT04931212
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new device (Smart-TO) that places a small balloon in the windpipe of unborn babies with congenital diaphragmatic hernia, a condition where the diaphragm has a hole and the lungs don't grow properly. The balloon is later removed using a special MRI technique. The goal was to see if the device works and is safe. 23 pregnant women participated, and the study focused on whether the balloon deflated and came out as planned, and on any side effects like early birth.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
23 people
The number who actually took part.
- Started
-
Aug 2021
- Finished
-
Sep 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18 years or more, who are able to consent, and affiliated to social security * Singleton pregnancy with fetus with isolated left-sided congenital diaphragmatic hernia (no additional malformation nor chromosomal abnormality) and: Severe pulmonary hypoplasia defined as observed on expected 'lung-to-head ration' (O/E LHR) \<25% irrespective of the liver position as measured between 27wks and 29wks + 6 days Or Moderate pulmonary hypoplasia defined as O/E LHR 25-34.9% (liver up or down) or O/E LHR 35-44.9% with liver up as measured between 30wks and 31wks + 6 days Exclusion Criteria: * Maternal contraindication to fetoscopic surgery * Preterm premature rupture of the membranes (PPROM) or condition strongly predisposing to PPROM or premature delivery * Impossibility of remain close to the FETO center during the fetal occlusion period
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Congenital diaphragmatic hernia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Bicêtre
Le Kremlin-Bicêtre, 94270, France
-
Hôpital Béclère
Clamart, 92140, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 3D models bring a Baby's birth defect into focus before birth?
- Can a tiny balloon in the womb save babies born with a hole in their diaphragm?
- Tiny balloon inside womb could help babies breathe
- Teens' sports struggles after rare birth defect surgery: study seeks answers
- New trial could change how doctors help CDH babies at birth
- Pioneering fetal surgery aims to save babies born with a hole in their diaphragm